Service
General
Information
 
Last Update: 03/12/2009
previous pageend of pagenext page
Part of the audited Consolidated Financial Statements and Management´s Analysis

Segment Performance Products - Business development

Innovative and high-growth specialties

Sales by division (million €)

Sales by division (million €) – Performance Products (pie chart)

The Performance Products segment consists of the Acrylics & Dispersions, Care Chemicals and Performance Chemicals divisions. Our customers use our products and services to make their processes more efficient and to offer products on the market that clearly stand out in the competition.

We increased sales to third parties by €105 million to €8,967 million (volumes 0%, prices 8%, portfolio –4%, currencies –3%). Income from operations increased to €787 million due to the high profitability of the Care Chemicals division.

For 2009, we expect significantly higher sales following the integration of the Ciba business. Due to difficult market conditions and acquisition-related charges, we expect income from operations to be below the level of 2008.

Sales Performance Products (million €)

Sales Performance Products (million €) (bar chart)

Income from operations Performance Products (million €)

Income from operations Performance Products (million €) (bar chart)

Factors influencing sales – Performance Products

Factors influencing sales – Performance Products (bar chart)
  Download (Download XLS xls, 18 kB)

Segment data Performance Products (million €)

 

 

2008

2007

Change in %

Sales to third parties

8,967

8,862

1.2

Thereof Acrylics & Dispersions

3,632

3,522

3.1

Care Chemicals

3,065

3,029

1.2

Performance Chemicals

2,270

2,311

(1.8)

Intersegmental transfers

422

361

16.9

Sales including intersegmental transfers

9,389

9,223

1.8

Income from operations before depreciation and amortization (EBITDA)

1,286

1,143

12.5

Income from operations (EBIT)
before special items

785

712

10.3

Income from operations (EBIT)

787

681

15.6

Income from operations (EBIT)
after cost of capital

138

24

475.0

EBITDA in percent of sales

14.3

12.9

Assets

6,352

6,397

(0.7)

Research and development expenses

231

267

(13.5)

Additions to property, plant and equipment
and intangible assets

432

434

(0.5)

previous pageto topnext page